Pharmaceutical Analytical Testing Outsourcing Market Research Report - Forecast till 2030

Pharmaceutical Analytical Testing Outsourcing Market Information: by Product Type (Raw Materials, API, Others), by Service (Bioanalytical Testing, Stability Testing, Others), by End User (Pharma Companies, Others), & by Region- Forecast till 2030

ID: MRFR/HC/5722-CR | April 2019 | Region: Global | 117 Pages         

Pharmaceutical Analytical Testing Outsourcing Market Speak to Analyst Request a Free Sample

Pharmaceutical Analytical Testing Outsourcing Market Overview


The Pharmaceutical Analytical Testing Outsourcing Market is expected to reach USD 7500 million by 2030 at 8.70% CAGR during the forecast period 2022-2030. The pharmaceutical analytical market plays a significant role in the development of drugs and its manufacturing process. Pharmaceutical Analytical Testing provides information about the quality of raw materials, finished products, and their safety.


Due to the rapid growth of the pharmaceutical industry, the rise in demand for analytical information on drug and their process development done by regulatory agencies are the leading causes of the Pharmaceutical Analytical Testing Outsourcing Market in the past few years.


Extensive research, improvement in accessibility, initiatives by the government, and growing awareness lead to the Market.  Pharmaceutical companies are focusing and investing their money in Research and Development to develop sustainable drugs. However, not many companies have extensive infrastructure which is suitable for all kinds of analytical testing.


The government and companies collaborate to fulfill the gap between demand and supply in the Market. It is predicted that the consumption of drugs will have a significant rise during the forecast period.

COVID -19 Analysis of Pharmaceutical Analytical Testing Outsourcing Market


The COVID-19 pandemic had a massive negative impact on various industries in different sectors. There was an enormous demand for extensive research and new drugs to fight against the highly contagious virus. The global Market had exponential growth due to increasing demand for food quality safety. Companies around the world collaborated worldwide for the production of efficient drugs and distributed them around various countries.


Market Dynamics


Market Drivers


The increase in therapeutics and pharmaceuticals needs specialized manufacturing of products, which can help the market grow. The regulatory agencies are introducing stringent rules and regulations to maintain the standards and focusing on analytical details for production.


In Market, the companies focus on customized care, affecting the lifecycle of products. Due to this reason, the market is observing a rapid growth in innovation and development of new products. Also, the invention of compound products called biosimilars led to an increase in different types of tests. Also, outsourcing services has emerged as a suitable option among various pharmaceuticals companies. The pharmaceutical companies are focusing on enhancing the products; technological advancements and innovations are expected to influence the Market.


Restraints


The global Pharmaceutical Analytical Testing Outsourcing Market is fragmented into various segments. One of the major market restraints is the dependence upon manufacturing organizations' performance, which may hinder the growth of the market. Another possible restraint is the privacy concerns, or data loss of the manufacturing pharmaceutical companies is also expected to hamper the market's development.


Opportunities


Many pharmaceutical companies are depended upon analytical testing to enhance productivity and monitor the whole process. The outsourcing of analytical testing allows various companies to handle complicated activities and focus upon main competencies.


The Global Market is expected to grow faster during the forecast period. The outsourcing of active pharmaceutical ingredients will reduce the investment in containment infrastructure, which is highly expensive. Also, various pharmaceutical companies provide expertise in pharmacology and in-house toxicology.


Cumulative Growth Analysis


The global Pharmaceutical Analytical Testing Outsourcing Market is growing steadily. The factors behind the growth are the rules and regulations set by governments around the world, improvement in the quality and safety of products, and patients' safety.


Value Chain Analysis


The increasing investment in research and development is a crucial strategy. It will help companies around the world with the low capability to manufacture efficient products.


Pharmaceutical Analytical Testing Outsourcing Market Segment Overview


The global Market is divided into product type, services, and end-user.


By Product



By Services



By End-User



By Region



  • Europe (Germany, France, Spain, Italy, U.K.)

  • North America (The U.S. and Canada)

  • Asia Pacific (India, Japan, China, Australia, and rest)

  • Latin America (Mexico, Brazil, and rest)

  • The Middle East and Africa (GCC, South Africa, and others)


Regional Analysis


The North American region has dominated the Market. It is anticipated to hold the largest market share due to the increasing rampancy of chronic disease and rapid growth of contract research organizations (CRO). It is a hub of top manufacturing companies that manufacture high-end, reliable, and complex pharmaceuticals. The gradual rise in the production of drugs to fulfill the demand in this region is one of the prominent factors influencing the market growth.


Asia-Pacific is the second-largest region which has recorded the highest growth in the Market. The pharmaceutical companies are focusing on investing in this region because of its low cost in development, capability to perform complex tasks, and GMP compliance growth. Also, the bulk manufacturers are available in developing countries like India, and China has pushed the market.


The European market has shown significant growth in Pharmaceutical Analytical Testing Outsourcing Market due to increased government funding to help the industry for research and development to avoid chronic diseases, improve the expenditure in the healthcare facilities, and develop pharmaceutical sectors.


It is estimated that the Middle East and African region will have the lowest growth due to lack of awareness, funds, proper healthcare facilities, and low per capita income.


Competitive Landscape of Pharmaceutical Analytical Testing Outsourcing Market


Several market players have dominated Pharmaceutical Analytical Testing Outsourcing Market by using several strategies like launching new products, business expansions, joint ventures, agreements, acquisitions, partnerships, etc., to boost their revenue and growth of their portfolio. Some of the leading market players include Boston Analytical (New Hampshire), Merck KGaA (Germany), West Pharmaceutical Services, Inc. (U.S.), Exova Group PLC (U.K.), Source BioScience (U.K.), etc. These companies are predicted to dominate the global market and generate good revenue in the upcoming years.


In the year 2019, August, Boston Analytical had opened a new office situated in Cambridge to expand its business.


Here is the list of competitive companies in the Market-



  • Boston Analytical (New Hampshire)

  • West Pharmaceutical Services, Inc. (U.S.)

  • Exova Group PLC (U.K.)

  • Source BioScience (U.K.)

  • Pace Analytical Services, Inc. (U.S.)

  • Merck KGaA (Germany), WuXi AppTec (US)

  • Toxikon (US), Eurofins Scientific (Belgium)

  • Intertek Group Plc (U.K.)

  • Eurofins Scientific (Luxembourg)

  • West Pharmaceutical Services Inc. (U.S.)

  • Charles River Laboratories International, Inc (U.S.)

  • SGS SA (U.K.)

  • Pharmaceutical Product Development, LLC (U.S.)

  • Source BioScience (U.K.)

  • WuXi AppTec (U.S.)


Recent Developments


The key market players have applied various Pharmaceutical Analytical Testing Outsourcing Market strategies such as mergers, acquisitions, development of the product, innovation of new products, etc.


Cambrex Corporation, in 2018, announced that it had acquired Halo Pharma. This step will help to strengthen Cambrex's position in the Market. The acquisition will help to provide biotechnological and pharmaceutical organizations with the development and manufacturing services.


In the year 2019 April, Charles River Laboratories International, Inc. announced its acquisition of Citoxlab. The acquisition will help Charles River expand its business due to the expertise of Citoxlab in providing services of CRO (Contract Research Organisation) to the countries in the European and North American region.  This is a crucial step taken by Charles Rives to expand business in Charles River Laboratories International, Inc.


STA Pharmaceutical Co. Ltd. announced its agreement for investment with the government of Shanghai in Jinshan District to build a new Research and Development center. The new investment will help to strengthen WuXiA STA’s development in manufacturing and development of pharmaceuticals.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 7500 million
  CAGR   8.7%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Services, and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Analytical (New Hampshire), Merck KGaA (Germany), West Pharmaceutical Services, Inc. (U.S.), Exova Group PLC (U.K.), Source BioScience (U.K.), etc
  Key Market Opportunities   Innovation And Launch Of New Tests To Check The Quality Of Products
  Key Market Drivers

  • Growing Pharmaceutical Industry
  • Increasing Demand For Analytical Details On Drugs And Process Development By Regulatory Agencies
  • Growing Prevalence Of Cancer And Infectious Diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Market Research Future States that Global Pharmaceutical Analytical Testing Outsourcing Market is estimated to reach USD 7500 Million by 2030

    Exova Group PLC (UK), Boston Analytical (New Hampshire), Charles River Laboratories International, Inc (US), West Pharmaceutical Services, Inc. (US)

    Global Pharmaceutical Analytical Testing Outsourcing Market is expected to register a CAGR of 8.7% during forecast period upto 2030

    Pharmaceutical Analytical Testing Outsourcing Market is driven by Increasing research and development in the pharmaceutical and biotechnology industry for the development of better treatment options for various chronic disease like cancer, diabetes, etc.

    The Americas is expected to hold the largest share of the global pharmaceutical analytical testing outsourcing market